Literature DB >> 23534572

Tolvaptan in autosomal dominant polycystic kidney disease.

François Jouret, Jean-Marie Krzesinski.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23534572     DOI： 10.1056/NEJMc1300762

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  2 in total

1.  ESRD from autosomal dominant polycystic kidney disease in the United States, 2001-2010.

Authors:  Scott Reule; Donal J Sexton; Craig A Solid; Shu-Cheng Chen; Allan J Collins; Robert N Foley
Journal:  Am J Kidney Dis       Date:  2014-08-16       Impact factor: 8.860

Review 2.  Metabolic Reprogramming and Reconstruction: Integration of Experimental and Computational Studies to Set the Path Forward in ADPKD.

Authors:  Roberto Pagliarini; Christine Podrini
Journal:  Front Med (Lausanne)       Date:  2021-11-24
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.